Journal of Inherited Metabolic Disease

, Volume 25, Issue 2, pp 119–125

Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: Outcome of treatment with amino acids

Authors

    • Department of Metabolic DiseasesUniversity Medical Center
    • Department of Pediatric Metabolic DiseasesUniversity Medical Centre Utrecht
  • M. Duran
    • Department of Metabolic DiseasesUniversity Medical Center
  • L. Van Maldergem
    • Centre de Génétique HumaineInstitut de Pathologie et de Génétique
  • M. Pineda
    • Department of Child NeurologyHospital Saint Joan de Deu
  • L. Dorland
    • Department of Metabolic DiseasesUniversity Medical Center
  • R. Gooskens
    • Department of Child NeurologyUniversity Medical Center Utrecht
  • J. Jaeken
    • Laboratory for Genetic Metabolic DiseasesAcademic Medical Centre
  • B. T. Poll-The
    • Department of Metabolic DiseasesUniversity Medical Center
    • Department of Child Neurology, Emma Children's HospitalAcademic Medical Centre
Article

DOI: 10.1023/A:1015624726822

Cite this article as:
De Koning, T.J., Duran, M., Maldergem, L.V. et al. J Inherit Metab Dis (2002) 25: 119. doi:10.1023/A:1015624726822

Abstract

Congenital microcephaly, intractable seizures and severe psycho-motor retardation characterize 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency, a disorder of L-serine biosynthesis. The enzyme defect results in low concentrations of serine and to a variable degree of glycine in plasma and cerebrospinal fluid. Short-term beneficial effects have been reported of oral treatment with the deficient amino acids. In this paper, we report the first follow-up data of amino acid therapy in five patients treated for 3–7.5 years. Different treatment regimes were used, but a favourable response to amino acids was observed in all patients. A major reduction in seizure frequency occurred in all patients; two patients became free of seizures. Amino acids were well tolerated and no adverse effects were documented. A progress of psychomotor development was only observed in one patient, diagnosed early and treated with a high dosage of L-serine. A favourable outcome of 3-PGDH deficiency depends on early diagnosis and treatment.

Copyright information

© Kluwer Academic Publishers 2002